Berkshire biomedical announces third webinar in investor series: “our path to market – how copa™ will reach its initial market and patients”

Berkshire biomedical reveals its strategic path to market, early adoption plans, and key milestones driving copa's clinical and commercial rollout. berkshire biomedical reveals its strategic path to market, early adoption plans, and key milestones driving copa's clinical and commercial rollout.
BRK-A Ratings Summary
BRK-A Quant Ranking